Table 1.
Demographic and Biochemical Characteristics of the Study Population
| Study groups | P‐values | ||||
|---|---|---|---|---|---|
| Control (n = 138) | DM (−) CHD (n = 112) | DM (+) CHD (n = 82) | 1P | 2P | |
| Gender (n, %) | 0.169 | 0.060 | |||
| Male | 82 (59.42%) | 76 (67.86%) | 38 (46.34%) | ||
| Female | 56 (40.58%) | 36 (32.14%) | 44 (53.66%) | ||
| Age (years) (X ± SD) | 56.39 ± 11.28 | 55.54 ± 10.87 | 58.00 ± 7.87 | 0.544 | 0.217 |
| BMI (kg/m2) | 25.26 ± 3.29 | 26.45 ± 3.18 | 26.21 ± 4.13 | 0.006 | 0.124 |
| ≥ 27kg/m2 | 39 (29.77%) | 54 (50.94%) | 26 (44.07%) | 0,001 | 0.055 |
| <27 kg/m2 | 92 (70.23%) | 52 (49.06%) | 33 (55.93%) | ||
| Smoking (n, %) | <0.001 | 0.201 | |||
| Never smoking | 76 (59.80%) | 33 (30.00%) | 47 (69.10%) | ||
| Current smoking | 51 (40.20%) | 77 (70.00%) | 21 (30.90%) | ||
| Alcohol consumption (n, %) | 0.992 | 0.167 | |||
| Consumers | 8 (16.00%) | 9 (16.10%) | 3 (6.80%) | ||
| Nonconsumers | 42 (84.00%) | 47 (83.90%) | 41 (93.20%) | ||
| SBP (mmHg) (X ± SD) | 121.35 ± 10.79 | 128.57 ± 30.12 | 133.12 ± 27.39 | 0.027 | 0.001 |
| DBP (mmHg) (X ± SD) | 74.34 ± 8.97 | 79.69 ± 15.62 | 81.45 ± 16.95 | 0.003 | 0.001 |
| TC (mmol/l) (X ± SD) | 4.93 ± 1.26 | 5.59 ± 1.39 | 5.04 ± 1.36 | <0.001 | 0.585 |
| TG (mmol/l) (X ± SD) | 1.59 ± 0.95 | 1.62 ± 0.74 | 1.80 ± 1.09 | 0.771 | 0.170 |
| LDL‐C (mmol/l) (X ± SD) | 3.18 ± 1.12 | 3.57 ± 1.11 | 3.08 ± 1.04 | 0.010 | 0.561 |
| HDL‐C (mmol/l) (X ± SD) | 1.11 ± 0.30 | 1.03 ± 0.18 | 0.98 ± 0.25 | 0.015 | 0.002 |
| VLDL‐C (mmol/l) (X ± SD) | 0.71 ± 0.36 | 0.73 ± 0.33 | 0.83 ± 0.55 | 0.769 | 0.092 |
| LVH (n, %) | NS | NS | |||
| Positive | – | 30 (30.90%) | 10 (31.30%) | ||
| Negative | – | 67 (69.10%) | 22 (68.70%) | ||
| Hypertension (n, %) | <0.001 | <0.001 | |||
| Positive | – | 41 (40.20%) | 44 (55.70%) | ||
| Negative | 104 (100%) | 61 (59.80) | 35 (44.30) | ||
| Family story (n, %) | 0.034 | 0.012 | |||
| Positive | 24 (24.74%) | 42 (38.53%) | 21 (45.65%) | ||
| Negative | 73 (75.26%) | 67 (61.47%) | 25 (54.35%) | ||
DM(+)CHD, coronary heart disease (CHD) patients with diabetes; DM(−)CHD, CHD patients without diabetes; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; LDL‐C, low‐density lipoprotein‐cholesterol; HDL‐C, high‐density lipoprotein‐cholesterol; VLDL‐C, very low‐density lipoprotein‐cholesterol; LVH, left ventricular hypertrophy. The results are shown as mean ± SD. n, number of individuals; parametric results are shown as mean ± SD; P1, control versus DM(−)CHD; P2, control versus DM(+) CHD; NS, nonspecific. Bold values of P indicate statistical significance.